CBFA2T3-GLIS2 Fusion Is Prevalent in Younger Patients with Acute Myeloid Leukemia and Associated with High-Risk of Relapse and Poor Outcome: A Children's Oncology Group Report

被引：0
|
作者：
Schuback, Heather L. [1 ]
Alonzo, Todd A. [2 ]
Gerbing, Robert B. [3 ]
Miller, Kristen L. [1 ]
Kahwash, Samir [4 ]
Heerema-Mckenney, Amy [5 ]
Hirsch, Betsy A. [6 ]
Raimondi, Susana C. [7 ]
Aplenc, Richard [8 ]
Gamis, Alan S. [9 ]
Meshinchi, Soheil [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ So Calif, Los Angeles, CA USA
[3] Childrens Oncol Grp, Monrovia, CA USA
[4] Nationwide Childrens Hosp, Columbus, OH USA
[5] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[6] Univ Minnesota, Minneapolis, MN USA
[7] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[8] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[9] Childrens Mercy Hosp, Kansas City, MO 64108 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group
    Getz, Kelly D.
    Alonzo, Todd A.
    Sung, Lillian
    Meshinchi, Soheil
    Gerbing, Robert B.
    Raimondi, Susana
    Hirsch, Betsy
    Loken, Michael
    Brodersen, Lisa Eidenschink
    Kahwash, Samir
    Choi, John
    Kolb, E. Anders
    Gamis, Alan
    Aplenc, Richard
    PEDIATRIC BLOOD & CANCER, 2022, 69 (01)
  • [32] High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group (vol 8, 115, 2015)
    Laszlo, George S.
    Alonzo, Todd A.
    Gudgeon, Chelsea J.
    Harrington, Kimberly H.
    Kentsis, Alex
    Gerbing, Robert B.
    Wang, Yi-Cheng
    Ries, Rhonda E.
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Gamis, Alan S.
    Meshinchi, Soheil
    Walter, Roland B.
    Journal of Hematology & Oncology, 2016, 9
  • [33] Body mass index associated with childhood and adolescent high-risk B-cell acute lymphoblastic leukemia risk: A Children's Oncology Group report
    Ghosh, Taumoha
    Richardson, Michaela
    Gordon, Peter M.
    Ryder, Justin R.
    Spector, Logan G.
    Turcotte, Lucie M.
    CANCER MEDICINE, 2020, 9 (18): : 6825 - 6835
  • [34] Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group
    Hardy, Kristina K.
    Kairalla, John A.
    Gioia, Anthony R.
    Weisman, Hannah S.
    Gurung, Meera
    Noll, Robert B.
    Hinds, Pamela S.
    Hibbitts, Emily
    Salzer, Wanda L.
    Burke, Michael J.
    Winick, Naomi J.
    Embry, Leanne
    PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
  • [35] High Expression of the Very Late Antigen-4 Integrin Independently Predicts Reduced Risk of Relapse and Improved Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Children's Oncology Group
    Walter, Roland B.
    Alonzo, Todd A.
    Gerbing, Robert B.
    Ho, Phoenix A.
    Smith, Franklin O.
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Gamis, Alan S.
    Franklin, Janet L.
    Hurwitz, Craig A.
    Loken, Michael R.
    Meshinchi, Soheil
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (17) : 2831 - 2838
  • [36] Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Zhang, Jinghui
    Mullighan, Charles G.
    Harvey, Richard C.
    Wu, Gang
    Chen, Xiang
    Edmonson, Michael
    Buetow, Kenneth H.
    Carroll, William L.
    Chen, I-Ming
    Devidas, Meenakshi
    Gerhard, Daniela S.
    Loh, Mignon L.
    Reaman, Gregory H.
    Relling, Mary V.
    Camitta, Bruce M.
    Bowman, W. Paul
    Smith, Malcolm A.
    Willman, Cheryl L.
    Downing, James R.
    Hunger, Stephen P.
    BLOOD, 2011, 118 (11) : 3080 - 3087
  • [37] Extremes of Weight Are Associated with Increased Treatment-Related Toxicity in High-Risk Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Orgel, Etan
    Sposto, Richard
    Malvar, Jemily
    Seibel, Nita L.
    Ladas, Elena J.
    Gaynon, Paul
    Freyer, David R.
    BLOOD, 2011, 118 (21) : 1525 - 1526
  • [38] TET2 Mutations Are Associated with Poor Outcome in Pediatric AML: A Report From the Children's Oncology Group
    Kutny, Matthew A.
    Alonzo, Todd A.
    Gerbing, Robert B.
    Geraghty, Daniel
    Gamis, Alan S.
    Lange, Beverly
    Heerema, Nyla A.
    Franklin, Janet
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Meshinchi, Soheil
    BLOOD, 2011, 118 (21) : 262 - 262
  • [39] Four versus five chemotherapy courses in patients with low risk acute myeloid leukemia: A Children's Oncology Group report.
    Getz, Kelly D.
    Alonzo, Todd Allen
    Sung, Lillian
    Meshinchi, Soheil
    Gerbing, Robert B.
    Raimondi, Susana
    Hirsch, Betsy A.
    Kahwash, Samir B.
    Choi, John
    Kolb, E. Anders
    Gamis, Alan S.
    Aplenc, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)
    Hardy, Kristina K.
    Embry, Leanne
    Kairalla, John A.
    Sharkey, Christina
    Gioia, Anthony R.
    Griffin, Danielle
    Berger, Carly
    Weisman, Hannah S.
    Noll, Robert B.
    Winick, Naomi J.
    PEDIATRIC BLOOD & CANCER, 2024, 71 (11)
12345